亚洲国产成人久久77-亚洲国产成人久久99精品-亚洲国产成人久久精品hezyo-亚洲国产成人久久精品动漫-人妖hd-人妖ts在线,一本道高清DVD在线视频,2020亚洲永久精品导航,国产久久视频在线视频观看

當(dāng)前位置: 首頁 JCRQ2 期刊介紹(非官網(wǎng))
Clinical Pharmacology-advances And Applications

Clinical Pharmacology-advances And ApplicationsSCIE

國際簡稱:CLIN PHARMACOL-ADV A  參考譯名:臨床藥理學(xué)進展與應(yīng)用

  • CiteScore分區(qū)

    Q2

  • JCR分區(qū)

    Q2

基本信息:
ISSN:1179-1438
是否OA:開放
是否預(yù)警:否
出版信息:
出版地區(qū):United Kingdom
出版商:Dove Medical Press
出版語言:English
研究方向:PHARMACOLOGY & PHARMACY
評價信息:
影響因子:3.1
CiteScore指數(shù):4.6
SJR指數(shù):0.7
SNIP指數(shù):0.87
發(fā)文數(shù)據(jù):
Gold OA文章占比:100.00%
研究類文章占比:63.64%
年發(fā)文量:11
英文簡介 期刊介紹 CiteScore數(shù)據(jù) JCR分區(qū) 常見問題

英文簡介Clinical Pharmacology-advances And Applications期刊介紹

Clinical Pharmacology Advances and Applications is an international academic journal dedicated to the field of clinical pharmacology. It publishes research articles on the mechanisms of action, pharmacodynamics, pharmacokinetics, pharmacogenomics, and personalized medicine of drugs in the human body. This journal aims to promote scientific advancements in clinical pharmacology and apply these advances to new drug development and patient treatment. The journal content not only includes basic research, but also involves practical applications such as clinical trial design, drug safety evaluation, and drug efficacy optimization.

Magazines play an important role in the field of clinical pharmacology, providing researchers with a platform to publish the latest research findings and evidence-based clinical decision support for doctors and pharmacists. The characteristics of the journal lie in its interdisciplinary research scope and in-depth exploration of key issues in the process of new drug development, which are crucial for improving the safety and effectiveness of drug therapy.

期刊簡介Clinical Pharmacology-advances And Applications期刊介紹

《Clinical Pharmacology-advances And Applications》該刊近一年未被列入預(yù)警期刊名單,目前已被權(quán)威數(shù)據(jù)庫SCIE收錄,得到了廣泛的認可。

該期刊投稿重要關(guān)注點:

  • 預(yù)計審稿時間: 16 Weeks
  • SCIE
  • 非預(yù)警

Cite Score數(shù)據(jù)(2024年最新版)Clinical Pharmacology-advances And Applications Cite Score數(shù)據(jù)

  • CiteScore:4.6
  • SJR:0.695
  • SNIP:0.865
學(xué)科類別 分區(qū) 排名 百分位
大類:Medicine 小類:Pharmacology (medical) Q2 110 / 272

59%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻計量指標(biāo)。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫中收集的引文為基礎(chǔ),針對的是前四年發(fā)表的論文的引文。CiteScore的意義在于,它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評價期刊影響力的方法,而不僅僅是通過影響因子(IF)這一單一指標(biāo)來評價。

歷年Cite Score趨勢圖

JCR分區(qū)Clinical Pharmacology-advances And Applications JCR分區(qū)

2023-2024 年最新版
按JIF指標(biāo)學(xué)科分區(qū) 收錄子集 分區(qū) 排名 百分位
學(xué)科:PHARMACOLOGY & PHARMACY ESCI Q2 126 / 354

64.5%

按JCI指標(biāo)學(xué)科分區(qū) 收錄子集 分區(qū) 排名 百分位
學(xué)科:PHARMACOLOGY & PHARMACY ESCI Q3 232 / 354

34.6%

JCR分區(qū)的優(yōu)勢在于它可以幫助讀者對學(xué)術(shù)文獻質(zhì)量進行評估。不同學(xué)科的文章引用量可能存在較大的差異,此時單獨依靠影響因子(IF)評價期刊的質(zhì)量可能是存在一定問題的。因此,JCR將期刊按照學(xué)科門類和影響因子分為不同的分區(qū),這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢圖

投稿常見問題